The mitotic cell cycle‐associated nomogram predicts overall survival in lung adenocarcinoma

Cancer statistics, 2023

(2023) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Integrative analysis of TP53 mutations in lung adenocarcinoma for immunotherapies and prognosis

(2023) He Li et al.   BMC BIOINFORMATICS

SWAN pathway-network identification of common aneuploidy-based oncogenic drivers

(2022) Robert R Bowers et al.   NUCLEIC ACIDS RESEARCH

Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma

(2022) Xiaodong Wang et al.   Bioengineered

Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma

(2022) Shijie Mai et al.   Frontiers in Endocrinology

The cell cycle, cancer development and therapy

(2022) Elaheh Jamasbi et al.   MOLECULAR BIOLOGY REPORTS

Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma

(2022) Jichang Liu et al.   Frontiers in Immunology

A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma

(2022) Xiaolong Tang et al.   Heliyon

Systemic analysis of the DNA replication regulator origin recognition complex in lung adenocarcinomas identifies prognostic and expression significance

(2022) Min Tang et al.   Cancer Medicine

Identification of lactate metabolism-related subtypes and development of a lactate-related prognostic indicator of lung adenocarcinoma

(2022) Xiaoyan Chang et al.   Frontiers in Genetics

Patients with neuregulin 1 (NRG1) rearranged cancer are suitable for the theranostic approach and targeted therapy

(2022) Ondrej Ondič et al.   Klinicka Onkologie

Future prospects for mitosis-targeted antitumor therapies

(2021) Alfonso Serrano-del Valle et al.   BIOCHEMICAL PHARMACOLOGY

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples

(2021) Wang Di et al.   CANCER SCIENCE

Mitosis-related gene CENP-U as a potential biomarker in malignancy

(2021) Changjian Shao et al.   Annals of Translational Medicine

Lung Cancer 2020

(2020) Brett C. Bade et al.   CLINICS IN CHEST MEDICINE

A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas

(2020) Guanzhang Li et al.   CNS Neuroscience & Therapeutics

Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma

(2019) Lei Zhang et al.   Journal of Translational Medicine

DNA replication licensing proteins: Saints and sinners in cancer

(2018) Muhammad Jameel Mughal et al.   SEMINARS IN CANCER BIOLOGY

Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation

(2017) Lindsey Araujo et al.   eLife

Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma

(2015) M B Schabath et al.   ONCOGENE

MicroRNA-26a/b Regulate DNA Replication Licensing, Tumorigenesis, and Prognosis by Targeting CDC6 in Lung Cancer

(2014) Xin Zhang et al.   MOLECULAR CANCER RESEARCH